Exendin-4 counteracts the effect of OA on the expression of lipogenesis genes in HepG2 cells Compared to untreated HepG2 cells, steatotic cells showed a significant upregulation of the lipogenesis genes SREBP-1, PPAR, FAS, CPT1A, SCD1, DGAT1, and DGAT2 (Fig
Yes, GLP-1 receptor agonist weight loss injections are generally safe for patients with well-controlled hypothyroidism on stable levothyroxine therapy
Yes, PlexusDx medications are HSA-eligible, and HSA accounts offer advantages for long-term GLP-1 therapy because balances roll over annually without expiration
Moving forward, a concerted effort to include more representative populations in research is essential to fully understand how GLP-1-based treatments influence taste perception across all demographics